SAN DIEGO--(BUSINESS WIRE)--May 4, 2006--Santarus, Inc. (NASDAQ: SNTS - News), a specialty pharmaceutical company focused on therapies for gastrointestinal diseases and disorders, today reported financial and operating results for the quarter ended March 31, 2006. Key financial results and highlights for the first quarter of 2006 included:
